Biotronik

Line

  • Christoph Böhmer
  • Lothar Krings

The Biotronik SE & Co. KG is a European company, privately owned by Max scarf Roof Jr., headquartered in Berlin ( Germany). Biotronik is a manufacturer of medical products and services for the electrotherapy of the heart.

The company offers complete solutions for diagnosis, treatment and therapy support in the areas of cardiac rhythm management, electrophysiology and vascular intervention. In the field of cardiac rhythm management of the Biotronik Home Monitoring service provides the physician with current online information about his pacemaker and defibrillator patients.

Biotronik has claims to approximately 5,600 people worldwide and maintains research facilities in Europe and North America.

History

The beginnings of Biotronik grounded in the development of Germany's first implantable pacemaker ( Biotronik IP -03) in 1963 by the physicist Max Gustav Julius scarf roof ( 1936-2001 ), who is also professor of biomedical engineering at the Friedrich -Alexander- University of Erlangen -Nuremberg (FAU ) was, and the electrical engineer Otto Franke. In the early years, the company dealt with the determination of capacity and service life of batteries for pacemakers and connection options between the electrode and the pacemaker, and between the electrodes and the heart.

In 1976, the company headquarters was inaugurated on Sieversufer 8 in Berlin- Neukölln. 1979, a production facility in Lake Oswego was built in the U.S. state of Oregon. This subsidiary resulted from the takeover of the U.S. pacemaker manufacturer Stimulation Technology, Inc.. At the same time began with the development and manufacture of hybrid circuits and assemblies for the medical device industry, including circuits for pacemakers. In the 1980s, the dual-chamber method (DDD ) was developed, and it could be produced pacemaker which spontaneous contractions of the heart were the priority and responded better to the actual demand. Biotronik developed for this purpose the Diplos 03, a programmable multi- DDD pacemaker with bidirectional telemetry.

In 1987, the relocation of the corporate headquarters in the Woermannkehre 1 From 1993, also included implantable cardioverter - defibrillators ( ICD ) to the product range, including the Phylax 03 In the 1990s, was also the closed-loop stimulation (CLS ) ( frequency matching ) developed when the pacemaker is integrated into the body's control system and thereby responds to the changing physical and mental stresses of the patient. Biotronik developed in 1991 the fractal coating implantable electrodes. This coating optimizes the electrically active surface of the electrode, thereby improving their electrical sensing and pacing characteristics. Biotronik is still the only manufacturer fractal coated electrodes.

Since 1994, a wide range of products for electrophysiology is offered and completed in 1995, the product range through the vascular intervention. This division develops and produces Biotronik balloon catheters and stents for the treatment of diseases of the coronary vessels. From 2000, with a complete Philos pacemakers family offered with telematics and there is the CE approval and initial implantation of a pacemaker with Home Monitoring ( remote data transfer ). 2005 Biotronik developed with the Lumos the world's first implantable cardioverter - defibrillator, which IEGMs ( intracardiac electrograms ) automatically transfers via mobile phone.

In 2007, Biotronik the EuroPCR 2007 Novelty Award from the European Association of Percutaneous Cardiovascular Interventions ( EAPCI ) for its technology of Absorbierbareren metal stents (AMS). In 2009, Biotronik was nominated with the home monitoring system for the German Future Prize.

2010 donated the Biotronik the technology Scientific Prize of the Berlin -Brandenburg Academy of Sciences in the same year, the company developed with the Lumax 540 VR - T DX, a single-chamber defibrillator system with comprehensive atrial diagnostics. In addition, the company entered into an international distribution partnership for the Endosense ablation catheter TactiCath with optical force sensor with Swiss medical technology company Endosense.

2012 acquired the former Biotronik Postfuhramt, a brick building on Oranienburger Straße in Berlin's Mitte district. In the Postfuhramt Biotronik will hold in future lectures, trainings and exhibitions. In addition, Biotronik brought his BioMonitor on the market - a implatierbarer heart monitor that can record and store heart rhythm gaps. In addition, Biotronik developed the world's first series of implantable pacemakers and defibrillators, which allow patients access to magnetic resonance imaging studies.

Since 2012 Biotronik, approved the first manufacturer for specific implantable cardioverter defibrillators and implants to heart failure therapy and magnetic resonance imaging examination under certain conditions and careful monitoring.

Divisions

  • Cardiac rhythm management: cardiac pacemakers, implantable defibrillators, electrodes, external monitoring and programming devices,
  • Electrophysiology: Products for electrophysiological studies and therapies, including ablation and diagnostic catheters,
  • Vascular Intervention Products for coronary and peripheral applications including stent systems, balloon catheters and guidewires.

Branches (selection)

  • Berlin- Neukölln, headquartered in Germany with 2,100 employees
  • Erlangen, center for technology and service with more than 130 employees
  • Rostock -Warnemünde, center of excellence for the development and production of stents
  • Vienna, Austria
  • Baar and Bülach, Switzerland
  • Vilvoorde, Belgium
  • São Paulo, Brazil ( since 1982)
  • Beijing, China
  • Hørsholm, Denmark
  • Rungis, France
  • Bicester, United Kingdom
  • New Delhi, Calcutta and Mumbai, India
  • Vimodrone, Italy
  • Tokyo, Japan
  • Toronto, Canada
  • Poznan, Poland
  • Seoul Mapo -gu, South Korea
  • Prague Nusle, Czech Republic
  • Lake Oswego, Oregon, USA

Products and therapies

  • Bradycardia: pacemaker (Evia, Entovis, Estella, Ecuro, Effecta ), electrodes ( Solia, Safio S, Siello, Setrox, Selos )
  • Tachyarrhythmia therapy: Defibrillators ( 3 Lumax family, Lumax 5 family, Lumax family 6, 7 Lumax family, Lumax VR - T DX), electrodes ( Linox smart)
  • Electrophysiology: ablation catheter ( AlCath gold, AlCath Flux, Flux AlCath gold, AlCath Flux eXtra Gold of VascoMed, Trignum Flux gold), controllable diagnostic catheter ( Lexx, ViaCath ), non- steerable diagnostic catheter ( MultiCath of VascoMed, Woxx )
  • Cardiac resynchronization: CRT Implanatete ( 3 Lumax family, Lumax 5 family, Lumax 7 family, Evia HF-T, Entovis HF-T ), electrodes ( Corox OTW, Sentus OTW UP), delivery systems and accessories ( Selectra, ScoutPro, ScoutPro IC )
  • Coronary vascular intervention: coronary sirolimus - eluting stent system ORSIRO, balloon - expandable cobalt chromium coronary stent PRO- Kinetic Energy, coronary paclitaxel- eluting balloon Pantera Lux, coronary balloon catheter ( Pantera, Pantera LEO, AngioSclupt PTCA), coronary guidewires (Streamer, Cruiser, Galeo Pro), drug- releasing absorbable stent made ​​of magnesium ( DREAMS )
  • Peripheral Vascular Intervention: Peripheral balloon - expandable stent systems (Dynamic, Dynamic Renal, PRO- Kinetic Energy Explorer ), peripheral self -expanding stent systems ( Astron, Astron Pulsar, Pulsar -18 ), peripheral balloon catheter ( Passeig -14, Passeig -18 Passeig. -35, AngioSculpt PTA, Elect Explorer ), peripheral guide wires ( Cruiser, Cruiser- 18, XT -14), introducer ( Fortress )
  • Implantable cardiac monitor for continuous remote monitoring of patients with atrial fibrillation or unexplained cardiovascular collapse ( BioMonitor )
  • External devices: ICS 3000, Reliaty, Renamic, Qiona Ablationspumpe, cardiac stimulator UHS 3000
  • Patient devices: CardioMessenger
Types of business entity Remote patient monitoring Baar, Switzerland Informationsdienst Wissenschaft
127065
de